AVD trades 541.5% below Wall Street's consensus target of $17.00.
Last 12 months price action with 12-month analyst target path
The base valuation assumes AVD achieves its forward estimates and maintains a stable P/E multiple of 7.0x. This scenario reflects the blended consensus of 13 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of June 21, 2026, American Vanguard Corporation (AVD) has a Wall Street consensus price target of $17.00, based on estimates from 13 covering analysts. With the stock currently trading at $2.65, this represents a potential upside of +541.5%. The company has a market capitalization of $76M.
Analyst price targets range from a low of $14.00 to a high of $20.00, representing a 35% spread in expectations. The median target of $17.00 aligns closely with the consensus average.
The current analyst consensus rating is Buy, with 9 analysts rating the stock as a Buy or Strong Buy,4 rating it Hold, and 0 rating it Sell or Strong Sell. The positive sentiment balance indicates moderate optimism about the stock prospects.
From a valuation perspective, AVD trades at a trailing P/E of -1.5x and forward P/E of 7.0x. Analysts expect EPS to grow +123.9% over the next year.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
MFINMedallion Financial Corp. | $224M | $9.53 | $10.50 | +10.2% | Hold | 8.5x | 9 |
HGBLHeritage Global Inc. | $43M | $1.25 | — | — | — | — | — |
CEVACEVA, Inc. | $1.4B | $49.72 | $45.40 | -8.7% | Buy | 94.2x | 25 |
REZIResideo Technologies, Inc. | $4.8B | $31.91 | $40.00 | +25.4% | Buy | 11.4x | 7 |
IOSPInnospec Inc. | $2.0B | $82.73 | $115.00 | +39.0% | Hold | 17.1x | 9 |
ASIXAdvanSix Inc. | $535M | $19.86 | $22.00 | +10.8% | Buy | 13.8x | 6 |
FMCFMC Corporation | $1.4B | $11.55 | $16.10 | +39.4% | Hold | 6.8x | 42 |
CTVACorteva, Inc. | $52.7B | $78.56 | $89.13 | +13.5% | Buy | 21.0x | 37 |
KRNTKornit Digital Ltd. | $777M | $16.76 | $17.00 | +1.4% | Buy | 94.4x | 13 |
PRLBProto Labs, Inc. | $1.9B | $81.06 | $38.50 | -52.5% | Hold | 40.1x | 17 |
Quick answers to the most common questions about buying AVD stock.
The consensus Wall Street price target for AVD is $17, representing 541.5% upside from the current price of $2.65. With 13 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.
AVD has a consensus rating of "Buy" based on 13 Wall Street analysts. The rating breakdown is predominantly bullish, with 9 Buy/Strong Buy ratings. The consensus 12-month price target of $17 implies 541.5% upside from current levels.
With a forward P/E of 6.9737x, AVD trades at a relatively low valuation. The consensus target of $17 implies 541.5% appreciation, suggesting meaningful undervaluation.
The most bullish Wall Street analyst has a price target of $20 for AVD, while the most conservative target is $14. The consensus of $17 represents the median expectation. These targets typically reflect 12-month expectations.
AVD is moderately covered, with 13 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 9 have Buy ratings, 4 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month AVD stock forecast based on 13 Wall Street analysts shows a consensus price target of $17, with estimates ranging from $14 (bear case) to $20 (bull case). The median consensus rating is "Buy".
AVD trades at a forward P/E ratio of 7.0x based on next-twelve-months earnings estimates. The higher forward P/E suggests near-term earnings pressure. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Wall Street analysts are very optimistic on AVD, with a "Buy" consensus rating and $17 price target (541.5% upside). 9 of 13 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
AVD analyst price targets range from $14 to $20, a 35% moderate spread showing some variance in outlooks. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $17 consensus represents the middle ground.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.